Your browser doesn't support javascript.
Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al.
Shah, Binita; Reyes, Aaron Z; Hu, Kelly A; Teperman, Jacob; Wampler Muskardin, Theresa L; Tardif, Jean-Claude; Pillinger, Michael H.
  • Shah B; Cardiology, New York University Grossman School of Medicine, New York, New York, USA.
  • Reyes AZ; Cardiology, VA New York Harbor Healthcare System, New York, New York, USA.
  • Hu KA; Medicine, New York University Grossman School of Medicinee, New York, New York, USA.
  • Teperman J; Medicine, New York University Grossman School of Medicinee, New York, New York, USA.
  • Wampler Muskardin TL; Medicine, New York University Grossman School of Medicinee, New York, New York, USA.
  • Tardif JC; Rheumatology, New York University Grosssman School of Medicine, New York, New York, USA.
  • Pillinger MH; Research Centre, Montreal Heart Institute, Montreal, Quebec, Canada.
Ann Rheum Dis ; 2021 Jan 28.
Article in English | MEDLINE | ID: covidwho-1054626
Semantic information from SemMedBD (by NLM)
1. Anti-Inflammatory Agents TREATS Responsive Disease
Subject
Anti-Inflammatory Agents
Predicate
TREATS
Object
Responsive Disease
2. Anti-Inflammatory Agents TREATS Responsive Disease
Subject
Anti-Inflammatory Agents
Predicate
TREATS
Object
Responsive Disease

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-219898

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-219898